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on different processes leading to neovascularisation on HUVECs including proliferation, 
adhesion and migration. HUVECs were incubated for 24h with DEET at concentrations 
similar to that found in plasma of exposed individuals (10-5M) or in the environment 
(10-8M) and VEGF (20 ng/mL) was used as a positive control. Proliferation was analyzed 
by using CyQUANT® Cell Proliferation Assay Kit. Evaluation of adhesion was performed 
using crystal violet staining. Cell migration was evaluated using Transwell® migration kit. 
Analysis of NO production and determination of AChE activity were performed using 
EPR technic and Ellman colorimetric assay, respectively. Both concentrations of DEET 
increased (i) proliferation, migration and adhesion of cultured endothelial cells and (ii) in 
vivo vascularization of Matrigel Plug. These cellular processes were associated with an 
enhancement of MMP2 activity, FAK phosphorylation and stress fi bers. Moreover, both 
concentrations of DEET stimulated NO production through an increase of peNOS-Ser/
peNOS-Thr ratio. Inhibition or silencing M3 muscarinic receptor subtype either with the 
pharmacological antagonist parafl uorohexahydrosiladiphenidol (pFHHSiD) or siRNA, 
respectively abolished the pro-angiogenic properties of DEET in both in vitro and in vivo 
conditions, despite the fact that it exerted dual dose-dependent effect on AChE activity. 
Indeed, low concentration of DEET (10-8M) enhanced AChE activity whereas higher 
concentration (10-5M) decreased it. These data underscore a novel property of DEET 
as a pro-angiogenic toxic, via the involvement of M3 muscarinic receptor subtype, that 
probably explains its potentiating effect on tumor development.
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Chronic hart failure (CHF) is charactarized by pathological cardiac hypertrophy, 
fi brosis and capillary rarefaction, causing cardiac dysfunction. Stimulation of angio-
genesis has been proposed as a treatment for cardiovascular diseases, but clinical 
results are diseppointing. We previously showed in a model of post-ischemic CHF 
(Banquet et al. Circ 2011) that angiogenic therapy based on targeted delivery of growth 
factors, Hepatocyte Growth Factor and Fibroblast Growth Factor-2, reduces cardiac 
dysfunction by preventing capillary rarefaction and reducing cardiac hypertrophy and 
fi brosis. However, the impact in non-ishemic CHF is unknown.
We used a model of non-ischemic CHF induced by transverse aortic constriction 
(TAC) in mice. Cardiac structure and function were evaluated by echography and 
hemodynamic, micoscopic and molecular enalyses, at 3 and 6 weeks post-TAC in 
control, treated or sham-operated mice.
TAC induced progressive cardiac hypertrophy and fi brosis leading to cardiac 
dysfunction, including decreased left ventricular (LV) fractional shortening at 3 weeks: 
27% in control vs 48% in sham, followed by LV dilatation. Angiogenic growth factor 
therapy tended to improve cardiac function by 3 weeks post-TAC: cardiac output: 
1,21 mL/min/g (therapy), 1,12 mL/min/g (control TAC), 1,48 mL/min/g (sham). 
However, at 6 weeks the cardiac dysfunction in treated mice was similar to TAC controls. 
The vascular density initially increased in controls mice at 3 weeks post-TAC, then 
decreased at 6 weeks, as compared with sham. However, the vessels-to-cardiomyocyte 
ration increased by 6 weeks: 0,74 in controls vs 0,89 in sham, indicative of inherent 
angiogenic response balancing the cardiac hypertrophy induced by TAC. Under 
these settings, and dissimilar to our fi ndings in ishemic CHF, our tagreted angiogenic 
therapy was unable to further improve myocardial vascularization, and did not 
reduce pathological cardiac hypertrophy or durably prevent cardiac dysfunction in 
non-ischemic CHF.
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The development of proximal coronary artery stems in the mouse heart: 
outgrowth of aortic endothelium and contribution of truncal endothelial cells
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The outfl ow tract (OFT) of the heart, site of conotruncal congenital heart defects 
such as common arterial trunk, forms by progressive addition of second heart fi eld 
progenitor cells from adjacent pharyngeal mesoderm. The DiGeorge syndrome candidate 
gene TBX1 is a critical regulator of second heart fi eld development and absence of 
Tbx1 in the mouse leads to OFT hypoplasia. Consistent with failure of myocardium 
at the base of the pulmonary trunk, the common arterial trunk in Tbx1 null embryos 
has an aorta-like myocardial domain with proximal coronary artery (CA) patterning 
defects. The left coronary ostium is predominantly located at the right/ventral sinus 
and the left CA courses across the normally coronary free ventral region of the heart, 
suggesting that subpulmonary myocardium is refractory to CA development. In order 
to investigate the mechanisms underlying these coronary anomalies we have studied 
proximal CA development in wild type and Tbx1 mutant hearts. In wild type embryos 
proximal CAs form when a plexus of truncal endothelial cells connects to endothelial 
buds emerging from the aortic sinuses at E11.5, prior to development of the ventricular 
coronary network. Fluorescent angiograms reveal expansion of the coronary tree from 
E12.5 and functional CAs from E14.5. The contribution of aortic endothelial cells to 
the proximal coronary stems was confi rmed using an inducible Cx40-Cre transgene 
expressed in outfl ow tract endothelium. Tbx1 affects the patterning but not timing of 
proximal CA development and a Tbx1-lacZ allele identifi es a myocardial expression 
domain specifi cally associated with the left CA, suggesting a potential role in defi ning 
the site of the left but not right ostium. Localization of these cells in hearts lacking 
Tbx1 and Sema3c, a model of common arterial trunk without OFT hypoplasia, suggests 
that positive as well as negative signaling events underlie proximal CA patterning.
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M3 receptor as a key target of N,N-diethyl-m-toluamide (DEET) to promote 
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The insect repellent DEET recently proposed as an inhibitor of acetylcholinesterase 
(AChE) has been reported to potentiate tumor development. As angiogenesis is a critical 
step in tumorigenesis, the present study was designed to test the potential effect of DEET 
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PPARα, WY-14643 (5μM), or in the presence of macrophage colony-stimulating 
factor (M-CSF) (20ng/ mL). In another set of experiments, cells were cultured in the 
presence of MPs from WT (MPsPPARα+/+) or KO (MPsPPARα-/-) mice, for 7 days.
Characterization of isolated cells at day 0 and after 7 days of culture was performed by 
fl ow cytometry using specifi c antibodies. PPARα deletion increases the population of 
EPCs and leukocyte progenitors. Seven days of culture induces expansion of EPCs and 
monocytic progenitor cells. Furthermore, PPARα deletion increases EPCs, monocytic 
(especially pro-infl ammatory monocytic) and leukocyte progenitor cells. WY-14643 
for 7 days has no effect on monocyte, leukocyte progenitors in both WT and PPARα 
defi cient mice. WY-14643 increases the ability of EPCs to promote in vivo bone 
marrow-derived cell-mediated angiogenesis when cells were originated from WT 
mice, but not from KO mice. Treatment with M-CSF of bone marrow-derived cells 
from WT but not those from KO mice induces an increase of monocytic progenitor 
cells. With regard to mature white blood cells, PPARα KO mice exhibits a reduced 
number of circulating lymphocytes compared to WT mice and a greater number of 
monocytes and neutrophils. These results indicate that PPARα negatively modulates 
the differentiation of bone marrow-derived progenitor cells and plays a role in the 
angiogenic ability of EPCs and in the production of white blood cells.
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Bone marrow-derived endothelial progenitor cells (EPCs) are critical for 
neovascularization. It has also been proposed that other populations of bone marrow-
derived cells can also be recruited to the injured endothelium and contribute to its 
regeneration. Here, we evaluated the effects of PPARα deletion on the phenotype 
of bone marrow-derived cells. Male C57BL/6N (20 weeks old) wild-type (WT) 
and PPARα-null (KO) were used. Bone marrow-derived cells obtained from WT 
or KO mice were cultured in the absence or in the presence of specifi c agonist 
